Dictionary

allow_url_fopen is ENABLED Dictionary Search

agio

Synonyms

Noun

1. agiotage

2. premium, exchange premium, charge

Usage
AGIO Stock Surges 35% in Six Months: What's Driving It? - Yahoo Finance
Agios Pharmaceuticals (AGIO) Stock Could Be 22% Undervalued After RISE UP Phase 3 Data - simplywall.st
Agios (NASDAQ: AGIO) director converts 1,976 RSUs, holds 8,049 shares - Stock Titan
Agios Pharmaceuticals, Inc. (AGIO) Discusses New Data and Strategic Expansion in Rare Hematology at EHA Investor Event - Slideshow (NASDAQ:AGIO) 2026-06-15 - Seeking Alpha
Agios Pharmaceuticals (AGIO) Is Up 7.4% After Mitapivat RISE UP Data in Sickle Cell Disease - Has The Bull Case Changed? - Sahm
Agios Pharmaceuticals (AGIO) Reports Promising Results from Phas - GuruFocus
Agios signs $165M deal for blood disorder drug from Korea’s Oscotec that flunked phase 2 study - Fierce Biotech
AGIO: Mitapivat shows durable efficacy in rare hematology, supporting growth and pipeline expansion - TradingView
Agios Pharmaceuticals Inc (AGIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Agios Pharmaceuticals (NASDAQ: AGIO) boosts 2023 stock plan by 2M shares - Stock Titan
How The Tebapivat Setback Is Reframing The Story For Agios Pharmaceuticals (AGIO) - Yahoo Finance
A Look At Agios Pharmaceuticals (AGIO) Valuation After The Cevidoplenib Licensing Agreement - Sahm
AGIOS (AGIO) director Catherine Owen Adams converts 1,976 RSUs into common stock - Stock Titan
Why Is Agios Pharmaceuticals (AGIO) Up 8.6% Since Last Earnings Report? - Yahoo Finance
Assessing Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Volatility - Yahoo Finance
AGIO Halts Tebapivat Development in Myelodysplastic Syndromes - Yahoo Finance
AGIO Secures Global Rights to Late-Stage Rare Blood Disorder Candidate - Yahoo Finance
Sickle cell patients needed fewer transfusions with Agios pill in Phase 3 - Stock Titan
A Look At Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Momentum - Yahoo Finance
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe - Yahoo Finance
Agios Pharmaceuticals Inc (AGIO) Institutional Confidence - TradingKey
Why Agios Pharmaceuticals (AGIO) Is Down 5.4% After Overhauling Its Hematology Portfolio - And What's Next - simplywall.st
Agios Pharmaceuticals Inc (AGIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AGIO: Mitapivat shows durable efficacy in rare anemias, supporting expansion and strong commercial prospects - TradingView
Agios Pharmaceuticals Inc (AGIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Agios Pharmaceuticals Inc (AGIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Agios Pharmaceuticals (AGIO) Is Up 5.4% After Mixed 2025 Results And AQVESME Launch Progress - Yahoo Finance
Rare blood disorder drug deal gives Agios shot at $1B U.S. sales - Stock Titan
A Look At Agios Pharmaceuticals (AGIO) Valuation After The Cevidoplenib Licensing Agreement - simplywall.st
BofA Reaffirms Buy Rating for Agios Pharmaceuticals (AGIO) - Yahoo Finance
Technical Reactions to AGIO Trends in Macro Strategies - Stock Traders Daily
Agios to stop tebapivat in LR-MDS, plans sickle cell data in 2H 2026 - Stock Titan
Agios Pharmaceuticals licenses global rights to Oscotec's SYK inhibitor cevidoplenib - Proactive financial news
Agios slides after discontinuing development of tebapivat in myelodysplastic syndromes (AGIO) - Yahoo Finance
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last? - Yahoo Finance
H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $54 - 富途牛牛
Do Upbeat EPS Revisions Before Earnings Quietly Reframe Agios Pharmaceuticals’ (AGIO) Risk‑Reward Profile? - Yahoo Finance
$AGIO stock is down 22% today. Here's what we see in our data. - Quiver Quantitative
Costco shoppers need to check their backyards immediately for this recalled patio swing - AL.com
Agios Pharmaceuticals Inc (AGIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Costco patio swings recalled after reports of injuries from falls - ABC News - Breaking News, Latest News and Videos
Here's Why Agios Pharmaceuticals Crashed 23% Today - Yahoo Finance
Agios to drop myelodysplastic syndromes drug (AGIO:NASDAQ) - Seeking Alpha
Agios Pharmaceuticals Inc (AGIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything - The Motley Fool
AGIO: Strategic ITP expansion with cevidoplenib offers strong clinical promise and disciplined financials - TradingView
J.P. Morgan Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Announces Target Price $31 - Moomoo
Allogene CEO to step down; Agios drug fails key test - Yahoo Finance
Why Did AGIO Stock Surge 14% Today? - Stocktwits
(AGIO) Volatility Zones as Tactical Triggers - Stock Traders Daily
Agios Halts Tebapivat Trials As Sickle Cell Focus Shapes Valuation - simplywall.st
Agios Pharmaceuticals Reports Positive Phase 3 Results for Mitapivat in Sickle Cell Disease, Highlighting Hemoglobin Response and Reduced Transfusion Burden - Quiver Quantitative
AGIO: Exclusive global license for cevidoplenib expands rare hematology pipeline and targets ITP - TradingView
Analysts’ Top Healthcare Picks: McKesson (MCK), Agios Pharma (AGIO) - The Globe and Mail
$AGIO stock is up 17% today. Here's what we see in our data. - Quiver Quantitative
Here's Why Agios Pharmaceuticals Crashed 23% Today - The Motley Fool
Agios (NASDAQ: AGIO) doubles mitapivat revenue and funds 2026 pipeline catalysts - Stock Titan
Agios Pharmaceuticals Inc (AGIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AGIO Maintained by JP Morgan -- Price Target Lowered to $31 - GuruFocus
Earnings Preview: Agios Pharmaceuticals (AGIO) Q1 Earnings Expected to Decline - Yahoo Finance
AGIO: Cevidoplenib licensed for ITP, with strong phase II data and phase III planned for 2028 - TradingView
Agio Ratings Secures $6 Million to Expand Risk Management Tools for Digital Assets - Business Wire
Agios Pharmaceuticals Secures Exclusive Global Rights to Next-Generation SYK Inhibitor Cevidoplenib for Immune Thrombocytopenia Treatment - Quiver Quantitative
Agios Pharmaceuticals (AGIO) Upgraded After Mixed Sickle Cell Data and Pending Thalassemia Catalyst - Yahoo Finance
Agios’ next-gen PK drug fails blood cancer study but sickle cell disease ambitions remain undimmed - Fierce Biotech
Agios Pharmaceuticals stock tumbles 25% after Novo data - Investing.com
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - Zacks Investment Research
Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) - Yahoo Finance
$AGIO stock is up 11% today. Here's what we see in our data. - Quiver Quantitative
How Agios’ Mitapivat sNDA And New SCD Trial Design At Agios Pharmaceuticals (AGIO) Has Changed Its Investment Story - Yahoo Finance
Agios: JPMorgan Healthcare Conference 2023 - Agios
Agios Pharmaceuticals (AGIO) Sees Significant Decline in Stock P - GuruFocus
Vanguard Capital Management (NASDAQ: AGIO) reports 3.09M shares, 5.27% ownership - Stock Titan
AGIO Stock Slumps 25% – What’s The Novo Connection? - Stocktwits
EU clears sole approved drug for adults with alpha- or beta-thalassemia - Stock Titan
AGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug Momentum - TradingView
New thalassemia drug writes 242 U.S. scripts as Agios plans sickle cell filing - Stock Titan
New pill for sickle cell moves to FDA review, aims to cut transfusions - Stock Titan
AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial - Stocktwits
Agios Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Availability of AQVESME™ for Thalassemia - Quiver Quantitative
Agios (NASDAQ: AGIO) CLO exercises 8,500 PSUs and sells shares for taxes - Stock Titan
Agios (AGIO) Q2 2025 Earnings Call Transcript - The Motley Fool
Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease - TradingView
Agios Pharmaceuticals, Inc. AGIO ) Stock Price Today & Analysis - Gotrade
Armistice Capital (NASDAQ: AGIO) holds 2.716M shares, 4.57% stake - Stock Titan
Oral drug lifts hemoglobin in sickle cell and thalassemia trial - Stock Titan
Agios (AGIO) Q1 2026 Earnings Call Transcript - The Motley Fool
Over 18K porch swings sold at Costco recalled. See affected products - USA Today
Is Agios Pharmaceuticals (AGIO) Pricing Reflect Its Recent Rebound And Long Term Track Record - simplywall.st
Analysts Offer Insights on Healthcare Companies: Becton Dickinson (BDX), Agios Pharma (AGIO) and Healthequity (HQY) - The Globe and Mail
Agios Stock Sinks 23% as NVO's PKR Activator Meets Goal in SCD Study - Yahoo Finance
Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why - Yahoo Finance
Digital asset rater Agio Ratings raises $6m from AlbionVC - FinTech Global
$AGIO stock is down 50% today. Here's what we see in our data. - Quiver Quantitative
Price-Driven Insight from (AGIO) for Rule-Based Strategy - Stock Traders Daily
RSU vesting triggers proposed Common Stock sale for AGIO (AGIO) - Stock Titan
This Biotech Just Lost Half Its Value As Its Rival Celebrated - Investor's Business Daily
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today - The Motley Fool
Agios Pharmaceuticals Announces FDA Approval of AQVESME™ for Anemia Treatment in Thalassemia, the First FDA-Approved Medicine for Both Non-Transfusion-Dependent and Transfusion-Dependent Forms | AGIO Stock News - Quiver Quantitative
Foreign Language Equivalents
Foreign Language Equivalents of 'agio'
Language Equivalent   Language Equivalent
French agio    Spanish
Misspellings - Typos
agi,   aigo,   agoo,   aagio,   agoi,   sgio,   agioo,   ago,   ahio,   agii,   aggio,   aguo,   agip,   gaio,   aio,   agiio,   afio,   gio
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z